4//SEC Filing
GIRGENTI STEVEN 4
Accession 0001493152-23-023821
CIK 0001712762other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:15 PM ET
Size
10.5 KB
Accession
0001493152-23-023821
Insider Transaction Report
Form 4
GIRGENTI STEVEN
DirectorExecutive Chairman
Transactions
- Award
Common Stock
2023-01-01$2.28/sh+8,227$18,758→ 869,326 total - Award
Common Stock
2023-07-01$1.83/sh+10,245$18,748→ 889,491 total - Award
Common Stock
2023-04-15$1.89/sh+9,920$18,749→ 879,246 total
Holdings
- 8,955(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Represents a grant from bioAffinity Technologies, Inc. (the "Issuer") to Mr. Girgenti of 8,227 restricted shares of common stock, par value $0.007 (the "Common Stock"), on January 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.
- [F2]Represents a grant from the Issuer to Mr. Girgenti of 9,920 restricted shares of Common Stock on April 15, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest one-third on the date of grant, one-third on May 1, 2023 and the remaining shares on June 1, 2023, provided Mr. Girgenti continues to serve as a director, and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.
- [F3]Represents a grant from the Issuer to Mr. Girgenti of 10,245 restricted shares of Common Stock, on July 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.
- [F4]Represents shares of Common Stock owned directly by the Cranye Girgenti Testamentary Trust (the "Trust") and indirectly by Mr. Girgenti, as co-trustee of the Trust, as previously reported on a Form 4 filed by Mr. Girgenti on November 8, 2022. Mr. Girgenti disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Such total number of shares of Common Stock owned by the Trust, and by Mr. Girgenti indirectly.
Documents
Issuer
bioAffinity Technologies, Inc.
CIK 0001712762
Entity typeother
Related Parties
1- filerCIK 0001055530
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 4:15 PM ET
- Size
- 10.5 KB